Patents by Inventor Daren Ure

Daren Ure has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DENDRITIC CELL POTENTIATION
    Publication number: 20100015163
    Abstract: A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
    Type: Application
    Filed: August 27, 2009
    Publication date: January 21, 2010
    Inventors: Larry R. Pease, Moses Rodriguez, Daren Ure, Loc T. Nguyen, Suresh Radhakrishnan
  • DENDRITIC CELL POTENTIATION
    Publication number: 20100009438
    Abstract: A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
    Type: Application
    Filed: August 14, 2009
    Publication date: January 14, 2010
    Inventors: Larry R. Pease, Moses Rodriguez, Daren Ure, Loc T. Nguyen, Suresh Radhakrishnan
  • DENDRITIC CELL POTENTIATION
    Publication number: 20080193467
    Abstract: A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
    Type: Application
    Filed: April 15, 2008
    Publication date: August 14, 2008
    Inventors: Larry R. Pease, Moses Rodriguez, Daren Ure, Loc T. Nguyen, Suresh Radhakrishnan
  • Dendritic cell potentiation
    Patent number: 7390888
    Abstract: A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
    Type: Grant
    Filed: July 8, 2005
    Date of Patent: June 24, 2008
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Larry R. Pease, Moses Rodriguez, Daren Ure, Loc T. Nguyen, Suresh Radhakrishnan
  • Dendritic cell potentiation
    Patent number: 7052694
    Abstract: A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: May 30, 2006
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Larry R. Pease, Moses Rodriguez, Daren Ure, Loc T. Nguyen, Suresh Radhakrishnan
  • Dendritic cell potentiation
    Publication number: 20050249737
    Abstract: A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
    Type: Application
    Filed: July 8, 2005
    Publication date: November 10, 2005
    Inventors: Larry Pease, Moses Rodriguez, Daren Ure, Loc Nguyen, Suresh Radhakrishnan
  • Treatment of central nervous system diseases by antibodies against glatiramer acetate
    Publication number: 20050019322
    Abstract: The present invention provides humanized polyclonal and humanized monoclonal antibodies directed against an epitope on glatiramer acetate, also known as Copolymer 1, Copolymer-1, Cop-1 or Cop. Additionally, the subject invention concerns a pharmaceutical composition comprising an antibody directed against an epitope on glatiramer acetate for the treatment of a disease associated with demyelination of central nervous system axons. Also encompassed by the subject invention is a method of treating a subject suffering from a disease associated with demyelination of central nervous system axons. The subject invention further contains methods of stimulating remyelination of central nervous system axons. In addition, the subject invention provides a method of stimulating proliferation of lymphocytes.
    Type: Application
    Filed: February 10, 2004
    Publication date: January 27, 2005
    Inventors: Moses Rodriguez, Daren Ure
  • Treatment of central nervous system diseases by antibodies against glatiramer acetate
    Patent number: 6800285
    Abstract: The present invention provides humanized polyclonal and humanized monoclonal antibodies directed against an epitope on glatiramer acetate, also known as Copolymer 1, Copolymer-1, Cop-1 or Cop. Additionally, the subject invention concerns a pharmaceutical composition comprising an antibody directed against an epitope on glatiramer acetate for the treatment of a disease associated with demyelination of central nervous system axons. Also encompassed by the subject invention is a method of treating a subject suffering from a disease associated with demyelination of central nervous system axons. The subject invention further contains methods of stimulating remyelination of central nervous system axons. In addition, the subject invention provides a method of stimulating proliferation of lymphocytes.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: October 5, 2004
    Inventors: Moses Rodriguez, Daren Ure
  • Dendritic cell potentiation
    Publication number: 20040014207
    Abstract: A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
    Type: Application
    Filed: July 16, 2002
    Publication date: January 22, 2004
    Inventors: Larry R. Pease, Moses Rodriguez, Daren Ure, Loc T. Nguyen, Suresh Radhakrishnan
  • Treatment of central nervous system diseases by antibodies against glatiramer acetate
    Publication number: 20020182210
    Abstract: The present invention provides humanized polyclonal and humanized monoclonal antibodies directed against an epitope on glatiramer acetate, also known as Copolymer 1, Copolymer-1, Cop-1 or Cop. Additionally, the subject invention concerns a pharmaceutical composition comprising an antibody directed against an epitope on glatiramer acetate for the treatment of a disease associated with demyelination of central nervous system axons. Also encompassed by the subject invention is a method of treating a subject suffering from a disease associated with demyelination of central nervous system axons. The subject invention further contains methods of stimulating remyelination of central nervous system axons. In addition, the subject invention provides a method of stimulating proliferation of lymphocytes.
    Type: Application
    Filed: June 20, 2001
    Publication date: December 5, 2002
    Inventors: Moses Rodriguez, Daren Ure